Scribd Logo
Upload

Welcome to Scribd!

  • 16 views

    Group Work Mis 415

    Uploaded by

    YB gaming
    This document contains graphs and charts comparing financial metrics of three pharmaceutical companies - Beacon, Reneta, and Beximco - over multiple years. It shows their earnings per share, total assets, total liabilities, return on investment, net interest margin, return on total assets, and net profit margin from 2018 to 2022.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    Group Work Mis 415

    Uploaded by

    YB gaming
    16 views2 pages
    This document contains graphs and charts comparing financial metrics of three pharmaceutical companies - Beacon, Reneta, and Beximco - over multiple years. It shows their earnings per share, total assets, total liabilities, return on investment, net interest margin, return on total assets, and net profit margin from 2018 to 2022.

    Original Description:

    Original Title

    group-work-mis-415

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This document contains graphs and charts comparing financial metrics of three pharmaceutical companies - Beacon, Reneta, and Beximco - over multiple years. It shows their earnings per share, total assets, total liabilities, return on investment, net interest margin, return on total assets, and net profit margin from 2018 to 2022.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    16 views2 pages

    Group Work Mis 415

    Uploaded by

    YB gaming
    This document contains graphs and charts comparing financial metrics of three pharmaceutical companies - Beacon, Reneta, and Beximco - over multiple years. It shows their earnings per share, total assets, total liabilities, return on investment, net interest margin, return on total assets, and net profit margin from 2018 to 2022.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 2

    Power BI Desktop Total liabilities of Beacon, Reneta and Beximco pharmaceuticals

    Earning per share of Beacon, Beximco, Reneta pharmaceuticals by year by year


    Beacon Reneta Beximco Beacon Reneta Beximco
    100%

    Beacon, Reneta and Beximco


    Beacon , Reneta and Beximco

    40

    50%

    20

    0%
    2018 2019 2020 2021 2022
    0 year
    2018 2019 2020 2021 2022
    Year

    ROI of Reneta, Beacon and Beximco pharmaceuticals by Year


    Total Asset of Reneta, Beximco and Beacon pharmaceuticals by Year
    Reneta Beacon Beximco
    Reneta Beximco Beacon
    30

    Reneta, Beacon and Beximco


    Reneta, Beximco and Beacon

    60K

    20

    40K

    10
    20K

    0K 0
    2018 2019 2020 2021 2022 2018 2019 2020 2021 2022
    Year Year
    Power BI Desktop

    Net interest Margin of Beacon, Reneta and Beximco


    pharmaceuticals by Year Return on Total Asset Beacon , Reneta and Beximco
    Beacon Reneta Beximco pharmaceuticals by Years
    Beacon Reneta Beximco
    Beacon, Reneta and Bexim…

    10
    40

    Beacon , Reneta and Beximco


    20
    5

    0
    2018 2019 2020 2021 2022
    Year
    0
    2018 2019 2020 2021 2022
    Years

    Net profit margin of Beximco, Reneta and Beacon pharmaceuticals


    by Years
    Beximco Reneta Beacon

    2022

    2021
    Years

    2020

    2019

    2018

    0% 50% 100%
    Beximco, Reneta and Beacon

    You might also like